Selecting a 503B outsourcing partner isn't a one-time procurement decision - it's an ongoing dependency your pharmacy will rely on every time a critical medication is out of stock, every time a compounding need exceeds in-house capacity. Getting the evaluation wrong doesn't just mean a bad vendor relationship; it means real exposure to recalls, compliance findings, and supply disruption at the worst possible moment. This guide walks through the same framework Quva uses internally to hold its own facilities accountable - so you can apply it to any partner you're evaluating, including us.
It’s tempting to evaluate a 503B partner primarily on cost and lead time. But a facility that’s cheap or fast today and non-compliant tomorrow can cost a health system far more, in recalled product, in FDA scrutiny that reflects back on your own pharmacy’s oversight, and in the operational chaos of an unplanned supply gap. Quality and compliance aren’t a separate line item from reliability; they’re what reliability is actually built on.
Ask how frequently the facility conducts environmental monitoring, what cleanroom classifications it maintains, and how often it performs media-fill testing. Ask, too, how aseptic technique and gowning qualifications are verified and re-certified for compounding staff. This is the foundation everything else depends on.
Confirm that the facility is currently registered with the FDA as a 503B outsourcing facility and remains in good standing. Check whether it holds current pharmacy licensure in your state specifically, not just in another state. Ask directly whether the facility has received any FDA Form 483 observations or warning letters, and how those issues were resolved. A facility with nothing to hide should be able to answer these questions without hesitation.
Review how lot numbers, beyond-use dates, and storage requirements are displayed on both primary and secondary packaging, and whether the format fits your pharmacy's existing scanning and dispensing workflows. Ask how the facility communicates labeling changes or corrections when they happen.
Ask what batch-release testing is performed and what the acceptance criteria are. Find out how out-of-specification results are investigated, and how quickly your pharmacy would be notified if a quality issue affected product you'd already received.
Quva is an FDA-registered 503B outsourcing facility built around this exact framework - cGMP-governed sterility assurance across multiple manufacturing sites, current registration and licensing across all 50 states, clear lot/BUD labeling designed to fit directly into hospital pharmacy workflows, and a quality control program with batch-release testing at every stage. See our manufacturing process and facilities for the specifics behind each of these.
For the complete question set in a fillable format, download our 503B outsourcing facility cGMP checklist - the same one Quva built for its own partner hospitals to use, on us or on anyone else.
Ready to see how Quva holds up against this framework directly? Talk with our team or explore our 503B outsourcing overview.